{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:39:18Z","timestamp":1780677558695,"version":"3.54.1"},"reference-count":30,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2020,7,3]]},"DOI":"10.3233\/cbm-190196","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T14:45:46Z","timestamp":1588949146000},"page":"293-299","source":"Crossref","is-referenced-by-count":11,"title":["CD133 expression and clinicopathologic significance in benign and malignant breast lesions"],"prefix":"10.1177","volume":"28","author":[{"given":"Ting Ting","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Pathology, Kunming General Hospital, Kunming, Yunnan, China"},{"name":"Department of Internal Medicine, West China Medical Center, Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue Feng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kunming General Hospital, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kunming General Hospital, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Lun","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kunming General Hospital, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"2","key":"10.3233\/CBM-190196_ref1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.3233\/CBM-190196_ref2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1089\/cbr.2012.1170","article-title":"5-aza-2\u2019-deoxycytidine enhances the radio-sensitivity of breast cancer cells","volume":"28","author":"Wang","year":"2013","journal-title":"Cancer Biother Radiopharm"},{"issue":"8","key":"10.3233\/CBM-190196_ref3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10585-007-9122-6","article-title":"New concepts in breast cancer metastasis: Tumor initiating cells and the microenvironment","volume":"24","author":"Sleeman","year":"2007","journal-title":"Clin Exp Metastasis"},{"key":"10.3233\/CBM-190196_ref4","doi-asserted-by":"crossref","unstructured":"M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison and M.F. Clarke, Prospective identification of tumorigenic breast cancer cells, Proc Natl Acad Sci U S A 100(7) (2003), 3983\u20133988.","DOI":"10.1073\/pnas.0530291100"},{"issue":"5","key":"10.3233\/CBM-190196_ref5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","article-title":"ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome","volume":"1","author":"Ginestier","year":"2007","journal-title":"Cell Stem Cell"},{"issue":"18","key":"10.3233\/CBM-190196_ref6","first-page":"5821","article-title":"Identification of a cancer stem cell in human brain tumors","volume":"63","author":"Singh","year":"2003","journal-title":"Cancer Res"},{"issue":"4","key":"10.3233\/CBM-190196_ref7","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.bbrc.2006.10.128","article-title":"Characterization of CD133+ hepatocellular carcinoma cells as cancer stem\/progenitor cells","volume":"351","author":"Suetsugu","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.3233\/CBM-190196_ref8","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.2353\/ajpath.2006.060498","article-title":"CD133+ renal progenitor cells contribute to tumor angiogenesis","volume":"169","author":"Bruno","year":"2006","journal-title":"Am J Pathol"},{"issue":"5","key":"10.3233\/CBM-190196_ref9","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.21873\/anticanres.11597","article-title":"The clinical significance of cancer stem cell markers ALDH1A1 and CD133 in lung adenocarcinoma","volume":"37","author":"Miyata","year":"2017","journal-title":"Anticancer Res"},{"issue":"14","key":"10.3233\/CBM-190196_ref10","doi-asserted-by":"crossref","first-page":"17751","DOI":"10.18632\/oncotarget.7474","article-title":"CD133 promotes gallbladder carcinoma cell migration through activating Akt phosphorylation","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.3233\/CBM-190196_ref11","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.18632\/oncotarget.7084","article-title":"Role of CD44 (high)\/CD133 (high) HCT-116 cells in the tumorigenesis of colon cancer","volume":"7","author":"Zhou","year":"2016","journal-title":"Oncotarget"},{"issue":"19","key":"10.3233\/CBM-190196_ref12","doi-asserted-by":"crossref","first-page":"8215","DOI":"10.7314\/APJCP.2014.15.19.8215","article-title":"Prognostic significance of expression of CD133 and Ki-67 in gastric cancer","volume":"15","author":"Saricanbaz","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"10.3233\/CBM-190196_ref13","doi-asserted-by":"crossref","first-page":"R10","DOI":"10.1186\/bcr1855","article-title":"Brca1 breast tumors contain distinct CD44+\/CD24- and CD133+ cells with cancer stem cell characteristics","volume":"10","author":"Wright","year":"2008","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.3233\/CBM-190196_ref14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/path.2254","article-title":"The basal-like breast carcinoma phenotype is regulated by SLUG gene expression","volume":"214","author":"Storci","year":"2008","journal-title":"J Pathol"},{"issue":"4","key":"10.3233\/CBM-190196_ref15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4048\/jbc.2015.18.4.347","article-title":"Prognostic impact and clinicopatho logical correlation of CD133 and ALDH1 expression in invasive breast cancer","volume":"18","author":"Kim","year":"2015","journal-title":"J Breast Cancer"},{"issue":"4","key":"10.3233\/CBM-190196_ref16","first-page":"1315","article-title":"Prognostic impact of CD133 immuno-expression in node-negative invasive breast carcinomas","volume":"31","author":"Ieni","year":"2011","journal-title":"Anticancer Res"},{"issue":"8","key":"10.3233\/CBM-190196_ref17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.prp.2011.05.013","article-title":"Hematopoietic progenitor cells (HPCs) in node-negative invasive breast carcinomas: Immunohistochemical analysis and clinicopathological correlations","volume":"207","author":"Giuffr\u00e8","year":"2011","journal-title":"Pathol Res Pract"},{"key":"10.3233\/CBM-190196_ref18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00428-014-1695-2","article-title":"Differential CD133 expression distinguishes malignant from benign papillary lesions of the breast","volume":"466","author":"Lin","year":"2015","journal-title":"Virchows Arch"},{"key":"10.3233\/CBM-190196_ref19","first-page":"980513","article-title":"ER81 expression in breast cancers and hyperplasia","volume":"2011","author":"Wang","year":"2011","journal-title":"Patholog Res Int"},{"issue":"7","key":"10.3233\/CBM-190196_ref20","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/archinte.160.7.953","article-title":"Mortality among women with ductal carcinoma in situ of the breast in the population-based on surveillance, epidemiology and end results program","volume":"160","author":"Ernster","year":"2000","journal-title":"Archives of Internal Medicine"},{"issue":"6859","key":"10.3233\/CBM-190196_ref21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"issue":"24","key":"10.3233\/CBM-190196_ref22","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1007\/s00018-007-7391-5","article-title":"Mammary stem cells and breast cancer","volume":"64","author":"Molyneux","year":"2007","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"10.3233\/CBM-190196_ref23","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"issue":"19","key":"10.3233\/CBM-190196_ref24","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1158\/1078-0432.CCR-06-0169","article-title":"Most ear1y disseminated cancer cells detected in bone marrow of breast cancer patients have a putagive breast cancer stem cell phenotype","volume":"12","author":"Balic","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"24","key":"10.3233\/CBM-190196_ref25","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/jnci\/djj495","article-title":"The response of CD24 (-\/low)\/CD44+ breast cancer-initiating cells to radiation","volume":"98","author":"Phillips","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.3233\/CBM-190196_ref26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: Role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.3233\/CBM-190196_ref27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000096854","article-title":"Differential expression of drug-resistance related genes between sensitive and resistant blasts in acute myeloid leukemia","volume":"117","author":"Eisele","year":"2007","journal-title":"Acta Haematol"},{"issue":"7120","key":"10.3233\/CBM-190196_ref28","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radio-resistance by proferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"issue":"14","key":"10.3233\/CBM-190196_ref29","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1158\/0008-5472.CAN-05-0592","article-title":"Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic","volume":"65","author":"Patrawala","year":"2005","journal-title":"Cancer Res"},{"issue":"6","key":"10.3233\/CBM-190196_ref30","first-page":"2111","article-title":"CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors","volume":"118","author":"Shmelkov","year":"2008","journal-title":"J Clin Invest"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-190196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:07:35Z","timestamp":1777385255000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-190196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,3]]},"references-count":30,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/cbm-190196","relation":{},"ISSN":["1875-8592","1574-0153"],"issn-type":[{"value":"1875-8592","type":"electronic"},{"value":"1574-0153","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,3]]}}}